Share chart Acusphere Inc
Extended chart
Simple chart
About
Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension. The company was formerly known as Polymers For Medicine, Inc. and changed its name to Acusphere, Inc. in March 2004. Acusphere, Inc. was founded in 1993 and is based in Watertown, Massachusetts.
| Change price per day: |
+900% (0.0001) |
| Change price per week: |
0% (0.001) |
| Change price per month: |
-90.91% (0.011) |
| Change price per 3 month: |
-96.2% (0.0263) |
| Change price per half year: |
-96.3% (0.027) |
| Change price per year: |
-95.93% (0.0246) |
| Change price per 3 year: |
-95.24% (0.021) |
| Change price per year to date: |
-96.67% (0.03) |
|
|
Underestimation
| Title |
Value |
Grade |
| P/S |
0 |
0 |
| P/BV |
0 |
0 |
| P/E |
0 |
0 |
| EV/EBITDA |
0 |
0 |
| Total: |
|
2.5 |
|
Efficiency
| Title |
Value |
Grade |
| ROA, % |
0 |
0 |
| ROE, % |
0 |
0 |
| Total: |
|
0 |
|
|
|
Dividends
| Title |
Value |
Grade |
| Div yield, % |
0 |
0 |
| DSI |
0 |
0 |
| Total: |
|
0 |
|
Debt
| Title |
Value |
Grade |
| Debt/EBITDA |
0 |
10 |
| Total: |
|
10 |
|
Growth impulse
| Title |
Value |
Grade |
| Yield Revenue, % |
56.57 |
7 |
| Yield Ebitda, % |
142.62 |
10 |
| Yield EPS, % |
-73.19 |
0 |
| Total: |
|
7.4 |
|
| Head |
Job title |
Payment |
Year of birth |
| Dr. William I. Ramage D.Phil |
Chief Development Officer |
|
1954 (70 years) |
